Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_assertion type Assertion NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_head.
- NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_assertion description "[Human proximal tubular epithelial cells (PTEC) were pretreated with PPAR-gamma agonist, rosiglitazone, and/or angiotensin II (AngII) type 1 receptor (ATR1) blocker (ARB), losartan, followed by activation with the conditioned medium collected from human mesangial cells incubated with pIgA1 (IgA-HMC) from patients with IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_provenance.
- NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_assertion evidence source_evidence_literature NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_provenance.
- NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_assertion SIO_000772 19443277 NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_provenance.
- NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_assertion wasDerivedFrom befree-20140225 NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_provenance.
- NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_assertion wasGeneratedBy ECO_0000203 NP935101.RAI0DAlDdz5PU-8ZCHXa76YzWqVTQ6XU_NhO2MBat-hpM130_provenance.